Eduard Molins

828 total citations
24 papers, 616 citations indexed

About

Eduard Molins is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Eduard Molins has authored 24 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 4 papers in Oncology. Recurrent topics in Eduard Molins's work include Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Asthma and respiratory diseases (9 papers) and Respiratory and Cough-Related Research (7 papers). Eduard Molins is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Asthma and respiratory diseases (9 papers) and Respiratory and Cough-Related Research (7 papers). Eduard Molins collaborates with scholars based in Spain, United States and United Kingdom. Eduard Molins's co-authors include Xavier Castells, Esther García Gil, Anne Leselbaum, Dave Singh, Eric Bateman, María Sala, Francesc Macià, Anthony D’Urzo, Paul Jones and Stephanie Korn and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Statistics in Medicine.

In The Last Decade

Eduard Molins

22 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduard Molins Spain 10 481 281 117 109 61 24 616
Nicola Pugliese Italy 13 43 0.1× 74 0.3× 35 0.3× 93 0.9× 49 0.8× 58 573
Wann-Cherng Perng Taiwan 11 128 0.3× 42 0.1× 31 0.3× 25 0.2× 36 0.6× 16 348
Brooks Kuhn United States 10 159 0.3× 70 0.2× 27 0.2× 13 0.1× 37 0.6× 38 350
Alexander Volodarskiy United States 7 43 0.1× 56 0.2× 30 0.3× 16 0.1× 47 0.8× 19 363
Sun Young Park South Korea 12 60 0.1× 23 0.1× 46 0.4× 188 1.7× 46 0.8× 30 358
Junfeng Li China 7 44 0.1× 20 0.1× 45 0.4× 79 0.7× 292 4.8× 24 667
Zhouming Xu China 8 66 0.1× 21 0.1× 16 0.1× 99 0.9× 35 0.6× 11 369
W. Swobodnik Germany 11 173 0.4× 19 0.1× 12 0.1× 137 1.3× 29 0.5× 63 417
Hamidreza Reihani Iran 13 52 0.1× 20 0.1× 22 0.2× 35 0.3× 31 0.5× 42 491
Nilakash Das Belgium 9 257 0.5× 87 0.3× 45 0.4× 8 0.1× 98 1.6× 22 394

Countries citing papers authored by Eduard Molins

Since Specialization
Citations

This map shows the geographic impact of Eduard Molins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduard Molins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduard Molins more than expected).

Fields of papers citing papers by Eduard Molins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduard Molins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduard Molins. The network helps show where Eduard Molins may publish in the future.

Co-authorship network of co-authors of Eduard Molins

This figure shows the co-authorship network connecting the top 25 collaborators of Eduard Molins. A scholar is included among the top collaborators of Eduard Molins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduard Molins. Eduard Molins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Franssen, Frits M.E., Swetlana Gaffron, Henrik Watz, et al.. (2022). Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study. SHILAP Revista de lepidopterología. 4 indexed citations
4.
D’Urzo, Anthony, Dave Singh, James F. Donohue, et al.. (2019). <p>Efficacy of aclidinium/formoterol 400/12 &micro;g, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT</p>. International Journal of COPD. Volume 14. 479–491. 6 indexed citations
5.
Sethi, Sanjay, Edward Kerwin, Henrik Watz, et al.. (2019). <p>AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD</p>. International Journal of COPD. Volume 14. 667–682. 16 indexed citations
6.
Singh, Dave, Anthony D’Urzo, James F. Donohue, et al.. (2019). <p>An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD</p>. International Journal of COPD. Volume 14. 2835–2848. 17 indexed citations
7.
Molins, Eduard, et al.. (2019). 4CPS-167 Study of the use of tapentadol. Section 4: Clinical pharmacy services. A147.1–A147. 2 indexed citations
8.
Watz, Henrik, Thierry Troosters, Kai Michael Beeh, et al.. (2017). ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD. International Journal of COPD. Volume 12. 2545–2558. 48 indexed citations
10.
Molins, Eduard, Erik Cobo, & Jordi Ocaña. (2017). Two‐stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?. Statistics in Medicine. 36(30). 4777–4788. 6 indexed citations
11.
Corral, Julieta, et al.. (2016). Long-term costs of colorectal cancer treatment in Spain. BMC Health Services Research. 16(1). 56–56. 21 indexed citations
14.
Singh, Dave, Paul Jones, Eric Bateman, et al.. (2014). Evaluation of the Efficacy and Safety of Two Doses of Aclidinium and Formoterol in Fixed-Dose Combination in Patients With COPD: The ACLIFORM Study. CHEST Journal. 145(3). 375A–375A. 7 indexed citations
16.
Bateman, Eric, et al.. (2014). Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on exacerbations in moderate-to-severe COPD: Pooled analysis of two studies. 44. 285. 4 indexed citations
17.
Redondo, A, Mercè Comas, Francesc Macià, et al.. (2012). Inter- and intraradiologist variability in the BI-RADS assessment and breast density categories for screening mammograms. British Journal of Radiology. 85(1019). 1465–1470. 123 indexed citations
18.
Molins, Eduard, Mercè Comas, Marta Román, et al.. (2009). Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme. Public Health. 123(9). 635–637. 3 indexed citations
19.
Molins, Eduard, et al.. (2008). Association between Radiologists' Experience and Accuracy in Interpreting Screening Mammograms. BMC Health Services Research. 8(1). 91–91. 39 indexed citations
20.
Novoa, Ana M., et al.. (2007). Evaluation of hand hygiene adherence in a tertiary hospital. American Journal of Infection Control. 35(10). 676–683. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026